MARKET

XBI

XBI

State Street® SPDR® S&P® Biotech ETF
NYSEARCA
160.46
+3.91
+2.50%
After Hours: 160.38 -0.08 -0.05% 19:59 07/02 EDT
OPEN
157.51
PREV CLOSE
156.55
HIGH
160.82
LOW
156.48
VOLUME
9.70M
TURNOVER
--
52 WEEK HIGH
160.82
52 WEEK LOW
81.67
TOTAL ASSET
10.93B
YTD YIELD
90.10%
1D
5D
1M
3M
1Y
5Y
1D
NervGen Pharma: I Think The Biggest Risks Are Now Behind It
Seeking Alpha · 2d ago
XBI, APGE, KYMR, TWST: Large Inflows Detected at ETF
NASDAQ · 2d ago
BTIG’s top small and mid-cap stocks for H2, ranked by SA Quant
Seeking Alpha · 3d ago
BTIG’s top large-cap stocks for the second half of 2026, ranked by SA Quant
Seeking Alpha · 3d ago
Most shorted stocks over $2B market cap
Seeking Alpha · 3d ago
U.S. Equity Markets: Lots Of Gambling Going On
Seeking Alpha · 4d ago
Biotech Is The Rate Cut Trade In Disguise
Seeking Alpha · 5d ago
Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It
Seeking Alpha · 5d ago
More
Profile
Fund Name
State Street® SPDR® S&P® Biotech ETF
Inception Date
2006-01-31
Benchmark
S&P 500 (TR) (1970)
Advisor Company
SPDR State Street Investment Management
Custodian
State Street Bank & Trust Co
Manager
Michael Feehily, Emiliano Rabinovich, Raymond Donofrio, Karl Schneider